As GLP-1 medications gain popularity among U.S. adults, health and fitness coaches are adapting their approaches to support clients using these drugs. This article explores seven distinct types of GLP-1 clients, emphasizing the importance of understanding each client's readiness…
A recent study led by Yale researchers explored how Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) affect the ability of patients with type 2 diabetes to discontinue insulin…
U.S. News & World Report has released its first ratings of telehealth platforms offering GLP-1 medications for weight loss, highlighting the importance of clinical oversight and p…
U.S. News and World Report has introduced its first evaluation of online providers offering GLP-1 medications, as many individuals seek telehealth options for weight loss. This in…
A recent study published in Nature reveals that rare mutations in the FNIP1 gene may help individuals burn fat instead of storing it, potentially lowering their risk of diabetes a…
Recent research indicates that GLP-1 agonists, such as Ozempic, may not only aid in weight loss but also reduce cravings for addictive substances like alcohol. This effect is link…
Chrissy Metz shares her experience with GLP-1 medications, discussing how they helped her manage food cravings and achieve weight loss. She emphasizes the complexities of obesity…
CeCe Olisa reflects on her journey with body positivity over the past two decades, highlighting the challenges and triumphs of being a plus-size woman. She shares her experiences…
Canadian grocery retailers are adapting their dairy aisles to meet the rising consumer demand for high-protein and gut-friendly products. As shoppers increasingly prioritize funct…
A recent study published in The BMJ indicates that tirzepatide, a GLP-1 medication, may lower the risk of major cardiovascular events by 33% in patients with type 2 diabetes and h…
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized orforglipron, making the UK the first country in Europe to approve this GLP-1 tablet for weight manag…
A recent clinical trial published in Nature Medicine reveals that aleniglipron, an oral GLP-1 medication, helped adults with obesity or overweight lose up to 12.1% of their body w…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…